VEGFA and neoplasm: VHL mutation is the most common event among all mutations, which stimulates vascular endothelial growth factor (VEGF) to proceed angiogenesis and tumor proliferation by modulating the stabilization of hypoxia-inducible factor (HIF) 1α and 2α (5).